Ascension All Saints Hospital, INC

Ascension All Saints Hospital, INC was paid $70.18M by Medicaid between Jan 2018 and Dec 2024, across 622 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 6.5% of everything it billed.

33Billing provider infoASCENSION ALL SAINTS HOSPITAL, INC
RACINE, WI 53405

33aNPI1639123284assigned 05/19/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$70.18M

24GClaims3,013,233

24DCodes billed622

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Wisconsin

Rank by total paid#3 of 60

Median peer was paid$2.90M

This provider vs. median24×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	468,383	$12.43M
2019	467,872	$11.68M
2020	378,739	$9.16M
2021	449,255	$10.04M
2022	428,918	$9.30M
2023	478,221	$9.79M
2024incomplete	341,845	$7.78M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	6.5%	93,334	76,499	$4.59M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.1%	66,372	58,647	$4.25M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	5.8%	82,950	71,024	$4.06M
96361	Intravenous infusion, hydration; each additional hour	5.1%	26,136	20,665	$3.55M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	4.5%	58,315	50,346	$3.14M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.4%	63,673	18,979	$2.40M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.9%	41,515	35,365	$2.02M
80053	Comprehensive metabolic panel	2.9%	114,191	93,915	$2.01M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	2.5%	21,913	20,005	$1.77M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	2.5%	46,448	39,986	$1.72M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	2.1%	46,436	39,979	$1.45M
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	1.8%	13,736	12,724	$1.27M

610 more codes

87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.5%	36,311	$1.07M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.3%	20,833	$904K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	1.3%	20,814	$891K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.2%	17,696	$858K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.1%	11,601	$798K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.1%	124,769	$773K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.1%	8,475	$758K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.1%	10,338	$741K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	14,847	$698K
70450	Computed tomography, head or brain; without contrast material	<1%	10,434	$670K
80048	Basic metabolic panel (calcium, ionized)	<1%	38,177	$648K
84702		<1%	17,339	$646K
81001		<1%	52,157	$636K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	13,963	$616K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	28,764	$569K
59025	Fetal non-stress test	<1%	8,371	$557K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	12,220	$554K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	7,713	$509K
80061	Lipid panel	<1%	43,172	$481K
G0378	Hospital observation service, per hour	<1%	14,322	$477K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	66,763	$466K
20610		<1%	7,202	$463K
84443	Thyroid stimulating hormone (TSH)	<1%	38,330	$460K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	17,681	$436K
99215	Doctor's office visit, returning patient (complex)	<1%	9,481	$429K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	18,453	$428K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	2,573	$425K
83036	Hemoglobin; glycosylated (A1C)	<1%	48,087	$415K
81025		<1%	37,679	$415K
87081		<1%	18,318	$401K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	5,444	$398K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	4,055	$383K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	11,203	$377K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	24,042	$375K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	8,658	$375K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	44,278	$363K
99203	Doctor's office visit, new patient (routine)	<1%	6,836	$331K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	16,001	$312K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,255	$302K
99204	Doctor's office visit, new patient (more involved)	<1%	6,261	$297K
97161		<1%	7,290	$288K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	760	$262K
87086	Culture, bacterial; quantitative colony count, urine	<1%	30,955	$252K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	4,658	$238K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,199	$228K
82962		<1%	19,941	$226K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	6,491	$222K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	3,327	$219K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,643	$218K
76830	Ultrasound, transvaginal	<1%	5,214	$215K
86481		<1%	3,138	$212K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	8,980	$211K
87634		<1%	3,327	$204K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	5,239	$201K
85027		<1%	37,167	$199K
76801		<1%	5,031	$197K
86780		<1%	20,864	$194K
93798		<1%	3,324	$192K
81003		<1%	30,836	$192K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,980	$187K
84484		<1%	21,489	$185K
90834	Psychotherapy session, about 45 minutes	<1%	4,240	$182K
87210		<1%	12,760	$178K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	1,094	$176K
82728		<1%	10,923	$171K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,229	$171K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	3,822	$171K
82607		<1%	13,914	$167K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	2,409	$159K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	3,620	$156K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,022	$155K
12001		<1%	1,869	$154K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	6,028	$150K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	7,713	$148K
80074		<1%	4,070	$147K
87653		<1%	4,245	$144K
82950		<1%	5,187	$136K
95806		<1%	1,522	$132K
76819	Fetal biophysical profile; without non-stress testing	<1%	7,761	$126K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	3,939	$125K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	766	$125K
81511		<1%	930	$124K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,056	$124K
71046	Radiologic examination, chest; 2 views	<1%	21,453	$124K
83690		<1%	20,846	$114K
80050	General health panel	<1%	9,740	$114K
83880		<1%	5,453	$114K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,023	$114K
97165		<1%	3,394	$112K
86803		<1%	9,465	$112K
99243		<1%	1,708	$111K
84439		<1%	13,484	$110K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,438	$105K
83655		<1%	8,634	$103K
20553		<1%	1,872	$100K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,504	$97K
86850		<1%	14,325	$96K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,846	$96K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,419	$96K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	2,206	$94K
12011		<1%	1,087	$94K
93971		<1%	2,988	$93K
87340		<1%	10,033	$92K
70496		<1%	1,474	$91K
76642		<1%	2,348	$90K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,506	$89K
87070		<1%	7,985	$89K
86762		<1%	6,335	$89K
80305		<1%	4,239	$86K
93975		<1%	1,822	$84K
H0015	Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education	<1%	1,222	$84K
62323		<1%	653	$83K
70498		<1%	1,503	$81K
86480		<1%	1,313	$80K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,779	$76K
85610		<1%	18,172	$70K
90715		<1%	6,655	$69K
93017		<1%	1,957	$69K
87186		<1%	9,383	$67K
84112		<1%	798	$67K
82746		<1%	6,337	$66K
77063	Screening digital breast tomosynthesis, bilateral	<1%	5,200	$64K
86703		<1%	3,667	$64K
11981		<1%	515	$63K
84153		<1%	3,474	$62K
96367		<1%	1,292	$62K
80143		<1%	3,439	$61K
83735		<1%	13,772	$60K
76536		<1%	1,468	$60K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,732	$60K
72141		<1%	975	$59K
82043		<1%	9,762	$57K
87077		<1%	6,362	$56K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	4,608	$56K
80076		<1%	4,864	$54K
76770		<1%	1,078	$53K
87147		<1%	8,205	$53K
83605		<1%	6,671	$53K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	284	$52K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	44,594	$49K
52000		<1%	209	$47K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	314	$47K
74018		<1%	5,014	$46K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	377	$46K
83550		<1%	6,760	$46K
71250		<1%	1,648	$45K
84703		<1%	5,395	$45K
82565		<1%	3,409	$44K
58300		<1%	681	$43K
12002		<1%	501	$42K
87505		<1%	390	$42K
85379		<1%	5,434	$42K
T1016	Case management, each 15 minutes	<1%	2,274	$42K
90686		<1%	6,079	$41K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	2,373	$41K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	1,305	$41K
83540		<1%	7,423	$40K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	33,101	$40K
84146		<1%	2,097	$40K
95811		<1%	232	$40K
83001		<1%	2,078	$38K
10060		<1%	479	$38K
97162		<1%	1,185	$38K
73110		<1%	4,795	$38K
73130		<1%	5,710	$37K
80179		<1%	3,403	$37K
70486		<1%	1,148	$37K
73610		<1%	6,252	$37K
87641		<1%	989	$36K
73630		<1%	7,351	$36K
86900		<1%	10,925	$35K
83970		<1%	1,262	$35K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	8,623	$35K
97803		<1%	2,056	$34K
97116		<1%	2,362	$34K
82570		<1%	7,396	$34K
95886		<1%	1,117	$33K
86901		<1%	11,677	$33K
87040		<1%	2,916	$33K
93970		<1%	841	$33K
88738		<1%	2,060	$32K
86706		<1%	3,424	$32K
76942		<1%	3,269	$31K
94060		<1%	1,647	$30K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	65	$29K
83020		<1%	2,443	$29K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	732	$29K
77066	Tomosynthesis, mammo	<1%	1,173	$29K
73560		<1%	5,062	$29K
85730		<1%	6,691	$28K
97802		<1%	1,408	$28K
83516		<1%	1,443	$28K
87522	Neg quan hep c or qual rna	<1%	672	$26K
86140		<1%	5,894	$26K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	137	$26K
11982		<1%	254	$25K
84403		<1%	1,156	$25K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	29	$25K
94729		<1%	2,488	$25K
J9271	Injection, pembrolizumab, 1 mg	<1%	20	$25K
73140		<1%	2,955	$25K
86235		<1%	566	$24K
82784		<1%	1,970	$23K
H2012	Behavioral health day treatment, per hour	<1%	1,366	$23K
G0008	Administration of influenza virus vaccine	<1%	9,774	$23K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	94	$23K
73221		<1%	351	$23K
82550		<1%	3,937	$22K
86038		<1%	2,212	$21K
73030		<1%	5,546	$21K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	382	$21K
85007		<1%	8,178	$21K
72100		<1%	3,365	$20K
87075		<1%	2,622	$20K
92567		<1%	866	$20K
82105		<1%	682	$20K
87529		<1%	425	$19K
84481		<1%	1,544	$19K
87088		<1%	2,659	$19K
92557		<1%	408	$18K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	109	$18K
90670		<1%	1,538	$18K
H1004	Prenatal care, at-risk enhanced service; follow-up home visit	<1%	630	$18K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	195	$17K
85652		<1%	7,085	$17K
86704		<1%	1,811	$17K
84550		<1%	3,743	$16K
36902		<1%	29	$16K
73564		<1%	3,029	$16K
77080		<1%	590	$16K
87205		<1%	3,897	$15K
73590		<1%	1,993	$14K
0042T		<1%	362	$14K
76870		<1%	241	$14K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	745	$14K
99406		<1%	3,449	$14K
94726		<1%	2,412	$14K
99205	Prolong outpt/office vis	<1%	391	$13K
84132		<1%	2,192	$13K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	351	$13K
73502		<1%	2,903	$13K
70491		<1%	219	$13K
71045	Radiologic examination, chest; single view	<1%	26,255	$13K
29848		<1%	28	$12K
84156		<1%	2,006	$12K
71271		<1%	348	$12K
64483		<1%	87	$12K
0002A		<1%	966	$12K
93296		<1%	632	$12K
H1003	Prenatal care, at-risk enhanced service; education	<1%	599	$12K
90674		<1%	1,185	$12K
99385		<1%	404	$11K
93351		<1%	88	$11K
73090		<1%	1,418	$11K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	9,330	$11K
0001A		<1%	990	$11K
96415		<1%	136	$11K
90651		<1%	502	$11K
82670		<1%	385	$11K
82077		<1%	936	$11K
36430		<1%	92	$11K
77065	Tomosynthesis, mammo	<1%	678	$11K
82800		<1%	1,404	$11K
76820		<1%	916	$10K
90792	Psychiatric diagnostic evaluation with medical services	<1%	127	$10K
95816		<1%	109	$10K
73080		<1%	1,839	$10K
80164		<1%	630	$9K
72114		<1%	459	$9K
86431		<1%	1,772	$9K
72052		<1%	309	$9K
91320		<1%	427	$9K
85049		<1%	1,335	$9K
77062		<1%	702	$9K
72110		<1%	1,281	$9K
82010		<1%	1,440	$9K
83615		<1%	1,845	$9K
99397		<1%	411	$8K
29125		<1%	234	$8K
58100		<1%	73	$8K
72040		<1%	996	$8K
86580		<1%	542	$7K
82075		<1%	689	$7K
85014		<1%	2,263	$7K
82150		<1%	1,335	$7K
82951		<1%	172	$7K
78815	Positron emission tomography (PET) for limited area imaging	<1%	40	$7K
82140		<1%	632	$7K
36000		<1%	449	$6K
72170		<1%	917	$6K
80177		<1%	532	$6K
86160		<1%	327	$6K
83520		<1%	406	$6K
43248		<1%	46	$6K
82465		<1%	1,428	$6K
29581		<1%	213	$6K
84100		<1%	1,847	$6K
84460		<1%	1,167	$6K
90472	Immunization administration, each additional vaccine (list separately)	<1%	4,162	$6K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	221	$5K
51798		<1%	2,188	$5K
87252		<1%	147	$5K
J0897	Injection, denosumab, 1 mg	<1%	86	$5K
97163		<1%	195	$5K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	74	$5K
90716		<1%	227	$5K
82553		<1%	1,030	$5K
86308		<1%	482	$5K
58301		<1%	90	$5K
99245		<1%	77	$5K
84165		<1%	633	$5K
G0424	Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day	<1%	87	$5K
83002		<1%	307	$5K
73565		<1%	2,920	$5K
86787		<1%	622	$5K
87449		<1%	480	$5K
77061		<1%	353	$5K
73562		<1%	1,786	$5K
90656		<1%	617	$5K
84450		<1%	890	$5K
86039		<1%	562	$5K
82803		<1%	256	$4K
82947		<1%	813	$4K
95819		<1%	66	$4K
86225		<1%	396	$4K
86696		<1%	257	$4K
85018		<1%	1,708	$4K
36415	Collection of venous blood by venipuncture	<1%	91,869	$4K
57454		<1%	35	$4K
Q3014	Telehealth originating site facility fee	<1%	1,644	$4K
93976		<1%	97	$4K
95909		<1%	102	$4K
71101		<1%	1,459	$4K
85046		<1%	679	$4K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	90	$4K
78580		<1%	18	$4K
86364		<1%	452	$3K
84480		<1%	272	$3K
88307		<1%	476	$3K
73552		<1%	686	$3K
11983		<1%	31	$3K
86923		<1%	97	$3K
96375	Therapeutic injection; each additional sequential IV push	<1%	24,971	$3K
36591		<1%	2,269	$3K
78830		<1%	19	$3K
86200		<1%	287	$3K
95874		<1%	53	$3K
94070		<1%	67	$3K
86695		<1%	241	$3K
96368		<1%	109	$3K
87563		<1%	122	$3K
95910		<1%	129	$3K
95813		<1%	26	$3K
77336		<1%	85	$3K
77091		<1%	349	$3K
74178		<1%	41	$3K
76813		<1%	120	$3K
20550		<1%	32	$3K
90480		<1%	258	$2K
93225		<1%	82	$2K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	16	$2K
19083		<1%	13	$2K
86255		<1%	209	$2K
64450		<1%	67	$2K
74183		<1%	31	$2K
90677		<1%	656	$2K
94150		<1%	4,647	$2K
84145		<1%	148	$2K
82627		<1%	101	$2K
29515		<1%	17	$2K
87109		<1%	157	$2K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,174	$2K
10061		<1%	14	$2K
31575		<1%	16	$2K
80175		<1%	87	$2K
97035		<1%	127	$2K
90837	Psychotherapy session, about an hour	<1%	36	$2K
G0009	Administration of pneumococcal vaccine	<1%	3,672	$2K
82533		<1%	129	$2K
72070		<1%	429	$2K
90662		<1%	1,157	$2K
90380		<1%	14	$2K
87536		<1%	16	$2K
87324		<1%	88	$2K
90633		<1%	606	$2K
86258		<1%	129	$2K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	421	$1K
90791	Psychiatric diagnostic evaluation	<1%	154	$1K
87110		<1%	87	$1K
93298		<1%	104	$1K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	19	$1K
64493		<1%	21	$1K
83037		<1%	296	$1K
88304		<1%	1,340	$1K
99386		<1%	49	$1K
82248		<1%	299	$1K
86376		<1%	71	$1K
72156		<1%	13	$1K
94375		<1%	155	$1K
96417		<1%	32	$1K
H1002	Prenatal care, at risk enhanced service; care coordination	<1%	34	$1K
80047		<1%	12	$1K
74019		<1%	755	$1K
64415		<1%	15	$1K
86618		<1%	60	$983.22
93226		<1%	83	$978.80
93321		<1%	15	$964.32
90734		<1%	177	$955.76
90732		<1%	464	$944.84
91300		<1%	257	$920.93
96150		<1%	28	$902.19
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	45	$883.23
73070		<1%	76	$872.50
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	145	$840.14
93242		<1%	127	$823.75
88142		<1%	56	$817.74
86593		<1%	131	$799.86
82378		<1%	98	$799.40
83721		<1%	155	$784.14
86334		<1%	59	$752.18
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	23	$736.91
99496		<1%	61	$732.21
76937		<1%	355	$720.12
80178		<1%	133	$719.53
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	176	$710.44
86800		<1%	37	$705.89
96160		<1%	433	$679.66
93922		<1%	61	$678.82
0124A		<1%	46	$674.32
0004A		<1%	109	$662.68
86141		<1%	57	$659.82
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	13,159	$637.45
90384		<1%	14	$622.65
73060		<1%	164	$621.86
84155		<1%	93	$599.90
73600		<1%	93	$562.56
85045		<1%	204	$558.81
84402		<1%	26	$549.85
90746		<1%	125	$546.18
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	16	$545.32
92587		<1%	13	$545.16
73700		<1%	14	$506.47
73620		<1%	31	$505.17
90707		<1%	111	$476.41
72050		<1%	84	$476.23
93299		<1%	27	$471.69
89051		<1%	28	$461.20
90714		<1%	104	$458.66
84704		<1%	32	$454.61
84163		<1%	32	$454.00
83525		<1%	45	$448.59
93880		<1%	13	$442.81
90713		<1%	192	$423.67
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	1,656	$422.81
87140		<1%	88	$421.76
90632		<1%	85	$417.10
77090		<1%	69	$412.77
90678		<1%	62	$407.06
88342		<1%	1,346	$382.63
99292		<1%	990	$379.37
51702		<1%	16	$372.81
90710		<1%	74	$370.14
82952		<1%	94	$369.24
G0010	Administration of hepatitis b vaccine	<1%	569	$362.93
90681		<1%	162	$362.32
69210		<1%	42	$361.69
96402		<1%	33	$346.94
87209		<1%	16	$329.36
90750		<1%	67	$323.85
86694		<1%	30	$311.61
96376		<1%	5,527	$310.81
83718		<1%	43	$285.65
94760		<1%	1,459	$280.30
82977		<1%	57	$279.63
82805		<1%	18	$279.37
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	805	$275.12
84270		<1%	14	$268.68
73660		<1%	68	$266.43
G0136	Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months	<1%	121	$253.76
90723		<1%	184	$248.30
70360		<1%	42	$236.15
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	12	$227.63
84436		<1%	25	$217.57
99407		<1%	254	$213.98
90698		<1%	174	$210.61
82247		<1%	59	$203.11
87329		<1%	12	$200.75
86870		<1%	109	$200.72
90687		<1%	28	$196.75
J3490	Unclassified drugs	<1%	694	$188.00
93325		<1%	16	$186.85
73000		<1%	68	$180.30
87338		<1%	15	$179.21
72220		<1%	29	$176.12
80171		<1%	18	$173.76
87177		<1%	16	$170.07
96153		<1%	343	$159.32
94762		<1%	45	$149.05
86765		<1%	14	$148.58
90739		<1%	21	$112.92
88112		<1%	31	$109.10
51701		<1%	61	$97.71
87206		<1%	13	$89.20
G0296	Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)	<1%	17	$85.24
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	3,549	$84.53
L3808	Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment	<1%	26	$83.31
73100		<1%	13	$82.49
94010		<1%	313	$81.90
82575		<1%	14	$80.03
0071A		<1%	17	$77.08
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	699	$74.54
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	23,058	$74.12
91307		<1%	63	$72.80
93270		<1%	14	$68.76
L1270	Addition to tlso, (low profile), abdominal pad	<1%	33	$63.83
90474		<1%	386	$62.51
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	12,254	$58.96
72072		<1%	13	$50.60
87185		<1%	14	$48.94
73523		<1%	14	$47.12
80069		<1%	13	$47.08
36416		<1%	216	$44.63
82330		<1%	15	$41.96
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	79	$38.40
0072A		<1%	20	$38.16
90744		<1%	13	$36.84
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	5,822	$29.42
J1953	Injection, levetiracetam, 10 mg	<1%	353	$24.83
99152		<1%	1,782	$22.65
C1769	Guide wire	<1%	2,794	$19.85
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,860	$19.02
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	8,378	$15.12
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	189	$12.60
99153	Mod sedat endo service >5yrs	<1%	1,107	$11.33
J2704	Injection, propofol, 10 mg	<1%	15,175	$9.97
J2270	Injection, morphine sulfate, up to 10 mg	<1%	7,277	$8.29
90696		<1%	13	$7.99
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	2,774	$6.31
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,451	$4.40
G0433	Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening	<1%	14	$3.66
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	21,193	$2.23
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,070	$1.89
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,779	$1.34
J0690	Injection, cefazolin sodium, 500 mg	<1%	7,389	$0.90
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	11,868	$0.44
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	5,774	$0.41
J1630	Injection, haloperidol, up to 5 mg	<1%	1,115	$0.27
J1644	Injection, heparin sodium, per 1000 units	<1%	2,716	$0.14
J2060	Injection, lorazepam, 2 mg	<1%	2,638	$0.08
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	2,521	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	3,205	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	267	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	701	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	1,159	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	172	$0.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	0%	4,319	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	504	$0.00
J1729	Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg	0%	266	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	102	$0.00
J3260	Injection, tobramycin sulfate, up to 80 mg	0%	56	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	86	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	106	$0.00
L3040	Foot, arch support, removable, premolded, longitudinal, each	0%	14	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	593	$0.00
A4550	Surgical trays	0%	43	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	175	$0.00
C1758	Catheter, ureteral	0%	17	$0.00
A6219	Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	0%	87	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	45	$0.00
91312		0%	19	$0.00
C1780	Lens, intraocular (new technology)	0%	32	$0.00
69209		0%	14	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	13	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	53	$0.00
31720		0%	61	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	20	$0.00
J0694	Injection, cefoxitin sodium, 1 gm	0%	21	$0.00
95913		0%	16	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	965	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	417	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	115	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	1,249	$0.00
J1726	Injection, hydroxyprogesterone caproate, (makena), 10 mg	0%	265	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	734	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	380	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	2,200	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	246	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	114	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	247	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	263	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	1,519	$0.00
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	1,159	$0.00
A9270	Non-covered item or service	0%	14,009	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	814	$0.00
C9399	Unclassified drugs or biologicals	0%	138	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	748	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	201	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	24	$0.00
88300		0%	116	$0.00
3008F		0%	232	$0.00
V2632	Posterior chamber intraocular lens	0%	67	$0.00
95911		0%	26	$0.00
88341		0%	46	$0.00
C1781	Mesh (implantable)	0%	16	$0.00
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	0%	19	$0.00
J7674	Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg	0%	52	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	18	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	78	$0.00
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	0%	47	$0.00
J1920	Injection, labetalol hydrochloride, 5 mg	0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMICHAEL MCCULLOUGH, MICHAEL (CFO)